YM 60828

Known as: YM-60828, YM60828 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Whereas heparin functions as an antithrombotic agent by promoting antithrombin III-based inhibition of thrombin and factor Xa… Expand
Is this relevant?
2003
2003
Compound YM-60828 was previously characterized in our laboratory as a potent, selective and orally-bioavailable Factor Xa (FXa… Expand
Is this relevant?
2002
2002
Since Factor Xa (FXa) is well known to play a central role in thrombosis and hemostasis, inhibition of FXa is an attractive… Expand
Is this relevant?
2002
2002
Factor Xa (FXa) is a serine protease which plays a pivotal role in the coagulation cascade. The inhibition of FXa has received… Expand
Is this relevant?
1998
1998
YM-60828 was found to potently inhibit human factor Xa following oral administration. YM-60828 showed high affinity for factor Xa… Expand
Is this relevant?
1998
1998
We examined the antithrombotic activity of a novel synthetic inhibitor of factor Xa, YM-60828, in an electrically-induced carotid… Expand
Is this relevant?
1998
1998
1. The effects of YM-60828, a newly synthesized factor Xa inhibitor, were investigated to analyse the relationship between its… Expand
Is this relevant?
1998
1998
The antithrombotic effects of a novel factor Xa inhibitor, YM-60828 ([N-[4-[(1-acetimidoyl-4-piperidyl)oxy]phenyl]-N-[(7-amidino… Expand
Is this relevant?
1998
1997
1997
The antithrombotic effects of intravenous infusions of YM-60828 ([N-[4-[(1-acetimidoyl-4-piperidyl)oxy]phenyl]-N-[(7-amidino-2… Expand
Is this relevant?